Costa Rica vs High income (World Bank): Hypertension effective treatment coverage (controlled hypertension)
Costa Rica
49.7%
in 2019
High income (World Bank)
36.0%
in 2019
Costa Rica rank
4th
High income (World Bank) rank
2nd
Hypertension effective treatment coverage (controlled hypertension) over time
- Costa Rica
- High income (World Bank)
How they compare
Costa Rica currently reports 49.7% against 36.0% in High income (World Bank), a difference of 13.7%.
That makes Costa Rica's figure about 1.4 times High income (World Bank)'s.
The two have swapped places 2 times across 30 shared years of data; in 1990 it was Costa Rica ahead.
Costa Rica ranks 4th and High income (World Bank) ranks 2nd of 193 countries.
Across the 3 decades both report, Costa Rica averaged higher in 1 and High income (World Bank) in 2.
Head to head by decade
| Decade | Costa Rica | High income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 11.7% | 12.4% | 0.8% | High income (World Bank) |
| 2000s | 21.4% | 24.0% | 2.5% | High income (World Bank) |
| 2010s | 41.1% | 34.2% | 6.9% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Costa Rica or High income (World Bank)?
- Costa Rica, at 49.7% against 36.0% in High income (World Bank) as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Costa Rica and High income (World Bank)?
- 13.7%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and High income (World Bank)?
- 30 years are reported by both, from 1990 to 2019.
- How do Costa Rica and High income (World Bank) rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Costa Rica ranks 4th and High income (World Bank) ranks 2nd of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.